The role of cardiac magnetic resonance imaging in defining the prognosis of patients with acute ST-segment elevation myocardial infarction. Part 2. Assessment of the disease prognosis

Cover Page

Cite item

Full Text

Abstract

Currently the incidence of congestive heart failure after ST-segment elevation myocardial infarction (STEMI) tends to increase. Reperfusion therapy is still the only effective method to reduce an infarct size. Therefore, there is a high unmet need of novel cardioprotective treatments that would improve outcomes in such patients. Recent advances in cardiovascular magnetic resonance (CMR) methods enabled the identification of certain new infarct characteristics associated with the development of heart failure and sudden cardiac death. These characteristics can help identify new groups of high risk patients and used as a targets for novel cardioprotective treatments. This part of the review summarizes novel CMR-based characteristics of myocardial infarction and their role in the prognostic stratification of STEMI patients.

About the authors

Mariya A. Terenicheva

Myasnikov Institute of Clinical Cardiology, National Medical Research Center of Cardiology

Author for correspondence.
Email: starcad@bk.ru
ORCID iD: 0000-0002-6064-4663

аспирант отд. неотложной кардиологии, врач-кардиолог палаты реанимации и интенсивной терапии 1-го кардиологического отд-ния ИКК им. А.Л. Мясникова

Russian Federation, Moscow

Olga V. Stukalova

Myasnikov Institute of Clinical Cardiology, National Medical Research Center of Cardiology

Email: starcad@bk.ru
ORCID iD: 0000-0001-8377-2388

канд. мед. наук, ст. науч. сотр. отд. томографии ИКК им. А.Л. Мясникова

Russian Federation, Moscow

Roman M. Shakhnovich

Myasnikov Institute of Clinical Cardiology, National Medical Research Center of Cardiology

Email: starcad@bk.ru
ORCID iD: 0000-0003-3248-0224

-р мед. наук, вед. науч. сотр. отд. неотложной кардиологии ИКК им. А.Л. Мясникова

Russian Federation, Moscow

Sergey K. Ternovoy

Myasnikov Institute of Clinical Cardiology, National Medical Research Center of Cardiology; Sechenov First Moscow State Medical University (Sechenov University)

Email: starcad@bk.ru
ORCID iD: 0000-0003-4374-1063

акад. РАН, д-р мед. наук, проф., гл. науч. сотр. отд. томографии ИКК им. А.Л. Мясникова, зав. каф. лучевой диагностики и лучевой терапии

Russian Federation, Moscow; Moscow

References

  1. Cahill TJ, Kharbanda RK. Heart failure after myocardial infarction in the era of primary percutaneous coronary intervention: Mechanisms, incidence and identification of patients at risk. World J Cardiol. 2017;9(5):407-15. doi: 10.4330/wjc.v9.i5.407
  2. Velagaleti RS, Pencina MJ, Murabito JM, et al. Long-term trends in the incidence of heart failure after myocardial infarction. Circulation. 2008;118(20):2057-62. doi: 10.1161/CIRCULATIONAHA.108.784215
  3. Bahit MC, Kochar A, Granger CB. Post-Myocardial Infarction Heart Failure. JACC Heart Fail. 2018;6(3):179-86. doi: 10.1016/j.jchf.2017.09.015
  4. Gerber Y, Weston SA, Enriquez-Sarano M, et al. Mortality Associated With Heart Failure After Myocardial Infarction: A Contemporary Community Perspective. Circ Heart Fail. 2016;9(1):e002460. doi: 10.1161/CIRCHEARTFAILURE.115.002460
  5. Priori SG, Blomstrom-Lundqvist C, Mazzanti A, et al. ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC) Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J. 2015;36(41):2793-867. doi: 10.1093/eurheartj/ehv316
  6. Al-Khatib SM, Stevenson WG, Ackerman MJ, et al. Ventricular Arrhythmia and Sudden Cardiac Death Prevention Guideline 2017 Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death. J Am Coll Cardiol. 2018;72(14):e91-e220. doi: 10.1016/j.jacc.2017.10.054
  7. Мареев В.Ю., Фомин И.В., Агеев Ф.Т., и др. Клинические рекомендации ОССН-РКО-РНМОТ. Сердечная недостаточность: хрони- ческая (ХСН) и острая декомпенсированная (ОДСН). Диагнос- тика, профилактика и лечение. Кардиология. 2018;58(6S):8-158 [Mareev VY, Fomin IV, Ageev FT, et al. Russian Heart Failure Society, Russian Society of Cardiology. Russian Scientific Medical Society of Internal Medicine Guidelines for Heart failure: chronic (CHF) and acute decompensated (ADHF). Diagnosis, prevention and treatment. Kardiologiia. 2018;58(6S):8-158 (in Russian)]. doi: 10.18087/cardio.2475
  8. Hall TS, von Lueder TG, Zannad F, et al. High-Risk Myocardial Infarction Database Initiative investigators. Relationship between left ventricular ejection fraction and mortality after myocardial infarction complicated by heart failure or left ventricular dysfunction. Int J Cardiol. 2018;272:260-6. doi: 10.1016/j.ijcard.2018.07.137
  9. Waks JW, Buxton AE. Risk Stratification for Sudden Cardiac Death After Myocardial Infarction. Annu Rev Med. 2018;69:147-64. doi: 10.1146/annurev-med-041316-090046
  10. Bhar-Amato J, Davies W, Agarwal S. Ventricular Arrhythmia after Acute Myocardial Infarction: "The Perfect Storm". Arrhythm Electrophysiol Rev. 2017;6(3):134-9. doi: 10.15420/aer.2017.24.1
  11. Kim HW, Farzaneh-Far A, Kim RJ. Cardiovascular magnetic resonance in patients with myocardial infarction: current and emerging applications. J Am Coll Cardiol. 2009;55:1-16. doi: 10.1016/j.jacc.2009.06.059
  12. Cohn JN, Ferrari R, Sharpe N. Cardiac remodeling – concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling. J Am Coll Cardiol. 2000;35(3):569-82. doi: 10.1016/s0735-1097(99)00630-0
  13. Pfeffer MA, Braunwald E. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation. 1990;81(4):1161-72. doi: 10.1161/01.cir.81.4.1161
  14. Bolognese L, Neskovic AN, Parodi G, et al. Left ventricular remodeling after primary coronary angioplasty: patterns of left ventricular dilation and long-term prognostic implications. Circulation. 2002;106(18):2351-7. doi: 10.1161/01.cir.0000036014.90197.fa
  15. McKay RG, Pfeffer MA, Pasternak RC, et al. Left ventricular remodeling after myocardial infarction: a corollary to infarct expansion. Circulation. 1986;74(4):693-702. doi: 10.1161/01.cir.74.4.693
  16. Bulluck H, Go YY, Crimi G, et al. Defining left ventricular remodeling following acute ST-segment elevation myocardial infarction using cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2017;19:26. doi: 10.1186/s12968-017-0343-9
  17. Wu E, Ortiz JT, Tejedor P, et al. Infarct size by contrast enhanced cardiac magnetic resonance is a stronger predictor of outcomes than left ventricular ejection fraction or end-systolic volume index: prospective cohort study. Heart. 2008;94(6):730-6. doi: 10.1136/hrt.2007.122622
  18. Westman PC, Lipinski MJ, Luger D, et al. Inflammation as a Driver of Adverse Left Ventricular Remodeling After Acute Myocardial Infarction. J Am Coll Cardiol. 2016;67(17):2050-60. doi: 10.1016/j.jacc.2016.01.073
  19. Carrabba N, Parodi G, Valenti R, et al. Prognostic value of reverse left ventricular remodeling after primary angioplasty for STEMI. Atherosclerosis. 2012;222(1):123-8. doi: 10.1016/j.atherosclerosis.2012.02.028
  20. Zhang L, Gooya A, Pereanez M, et al. Automatic Assessment of Full Left Ventricular Coverage in Cardiac Cine Magnetic Resonance Imaging with Fisher Discriminative 3D CNN. IEEE Trans Biomed Eng. 2018. doi: 10.1109/TBME.2018.2881952
  21. Bodi V, Monmeneu JV, Ortiz-Perez JT, et al. Prediction of Reverse Remodeling at Cardiac MR Imaging Soon after First ST-Segment-Elevation Myocardial Infarction: Results of a Large Prospective Registry. Radiology. 2016;278(1):54-63. doi: 10.1148/radiol.2015142674
  22. Friedrich MG. Myocardial edema – a new clinical entity? Nat Rev Cardiol. 2010;7(5):292-6. doi: 10.1038/nrcardio.2010.28
  23. DiBona DR, Powell WJ, Jr. Quantitative correlation between cell swelling and necrosis in myocardial ischemia in dogs. Circ Res. 1980;47:653-65. doi: 10.1161/01.RES.47.5.653
  24. Laine GA, Granger HJ. Microvascular, interstitial, and lymphatic interactions in normal heart. 1985;249(4 Pt. 2):H834-42. doi: 10.1152/ajpheart.1985.249.4.H834
  25. Symons R, Pontone G, Schwitter J, et al. Long-Term Incremental Prognostic Value of Cardiovascular Magnetic Resonance After ST-Segment Elevation Myocardial Infarction: A Study of the Collaborative Registry on CMR in STEMI. JACC Cardiovasc Imaging. 2018;11(6):813-25. doi: 10.1016/j.jcmg.2017.05.023
  26. Dongaonkar RM, Stewart RH, Geissler HJ, Laine GA. Myocardial microvascular permeability, interstitial oedema, and compromised cardiac function. Cardiovasc Res. 2010;87(2):331-9. doi: 10.1093/cvr/cvq145
  27. Garcia-Dorado D, Oliveras J. Myocardial oedema: a preventable cause of reperfusion injury? Cardiovasc Res. 1993;27(9):1555-63. doi: 10.1093/cvr/27.9.1555
  28. Dall'Armellina E, Karia N, Lindsay AC, et al. Dynamic changes of edema and late gadolinium enhancement after acute myocardial infarction and their relationship to functional recovery and salvage index. Circ Cardiovasc Imaging. 2011;4(3):228-36. doi: 10.1161/CIRCIMAGING.111.963421
  29. Nilsson JC, Nielsen G, Groenning BA, et al. Sustained postinfarction myocardial oedema in humans visualised by magnetic resonance imaging. Heart. 2001;85(6):639-42. doi: 10.1136/heart.85.6.639
  30. Ripa RS, Nilsson JC, Wang Y, et al. Short- and long-term changes in myocardial function, morphology, edema, and infarct mass after ST-segment elevation myocardial infarction evaluated by serial magnetic resonance imaging. Am Heart J. 2007;154(5):929-36. doi: 10.1016/j.ahj.2007.06.038
  31. Abdel-Aty H, Cocker M, Meek C, et al. Edema as a very early marker for acute myocardial ischemia: a cardiovascular magnetic resonance study. J Am Coll Cardiol. 2009;53(14):1194-201. doi: 10.1016/j.jacc.2008.10.065
  32. Cury RC, Shash K, Nagurney JT, et al. Cardiac magnetic resonance with T2-weighted imaging improves detection of patients with acute coronary syndrome in the emergency department. Circulation. 2008;118(8):837-44. doi: 10.1161/CIRCULATIONAHA.107.740597
  33. van Kranenburg M, Magro M, Thiele H, et al. Prognostic value of microvascular obstruction and infarct size, as measured by CMR in STEMI patients. JACC Cardiovasc Imaging. 2014;7(9):930-9. doi: 10.1016/j.jcmg.2014.05.010
  34. Carrick D, Haig C, Ahmed N, et al. Myocardial Hemorrhage After Acute Reperfused ST-Segment-Elevation Myocardial Infarction: Relation to Microvascular Obstruction and Prognostic Significance. Circ Cardiovasc Imaging. 2016;9(1):e004148. doi: 10.1161/CIRCIMAGING.115.004148
  35. Wu KC, Gerstenblith G, Guallar E, et al. Combined cardiac magnetic resonance imaging and C-reactive protein levels identify a cohort at low risk for defibrillator firings and death. Circ Cardiovasc Imaging. 2012;5(2):178-86. doi: 10.1161/CIRCIMAGING.111.968024
  36. Carberry J, Carrick D, Haig C, et al. Persistent Iron Within the Infarct Core After ST-Segment Elevation Myocardial Infarction: Implications for Left Ventricular Remodeling and Health Outcomes. JACC Cardiovasc Imaging. 2018;11(9):1248-56. doi: 10.1016/j.jcmg.2017.08.027
  37. Amier RP, Tijssen RYG, Teunissen PFA, et al. Predictors of Intramyocardial Hemorrhage After Reperfused ST-Segment Elevation Myocardial Infarction. J Am Heart Assoc. 2017;6(8):e005651. doi: 10.1161/JAHA.117.005651
  38. Mather AN, Fairbairn TA, Ball SG, et al. Reperfusion haemorrhage as determined by cardiovascular MRI is a predictor of adverse left ventricular remodelling and markers of late arrhythmic risk. Heart. 2011;97:453-9. doi: 10.1136/hrt.2010.202028
  39. Cokic I, Kali A, Wang X, et al. Iron deposition following chronic myocardial infarction as a substrate for cardiac electrical anomalies: initial findings in a canine model. PLoS One. 2013;8:e73193. doi: 10.1371/journal.pone.0073193
  40. Cokic I, Kali A, Yang HJ, et al. Iron-Sensitive Cardiac Magnetic Resonance Imaging for Prediction of Ventricular Arrhythmia Risk in Patients With Chronic Myocardial Infarction: Early Evidence. Circ Cardiovasc Imaging. 2015;8(8):10.1161/CIRCIMAGING.115.003642 e003642. doi: 10.1161/CIRCIMAGING.115.003642
  41. Klem I, Weinsaft JW, Bahnson TD, et al. Assessment of myocardial scarring improves risk stratification in patients evaluated for cardiac defibrillator implantation. J Am Coll Cardiol. 2012;60(5):408-20. doi: 10.1016/j.jacc.2012.02.070
  42. Kwong RY, Sattar H, Wu H, et al. Incidence and prognostic implication of unrecognized myocardial scar characterized by cardiac magnetic resonance in diabetic patients without clinical evidence of myocardial infarction. Circulation. 2008;118(10):1011-20. doi: 10.1161/CIRCULATIONAHA.107.727826
  43. Chen Z, Sohal M, Voigt T, et al. Myocardial tissue characterization by cardiac magnetic resonance imaging using T1 mapping predicts ventricular arrhythmia in ischemic and non-ischemic cardiomyopathy patients with implantable cardioverter-defibrillators. Heart Rhythm. 2015;12(4):792-801. doi: 10.1016/j.hrthm.2014.12.020
  44. Disertori M, Gulizia MM, Casolo G, et al. Improving the appropriateness of sudden arrhythmic death primary prevention by implantable cardioverter-defibrillator therapy in patients with low left ventricular ejection fraction. Point of view. J Cardiovasc Med (Hagerstown). 2016;17:245-55. doi: 10.2459/JCM.0000000000000368
  45. Kazbanov IV, ten Tusscher KH, Panfilov AV. Effects of Heterogeneous Diffuse Fibrosis on Arrhythmia Dynamics and Mechanism. Sci Rep. 2016;6:20835. doi: 10.1038/srep20835
  46. Iles L, Pfluger H, Lefkovits L, et al. Myocardial fibrosis predicts appropriate device therapy in patients with implantable cardioverter-defibrillators for primary prevention of sudden cardiac death. J Am Coll Cardiol. 2011;57(7):821-8. doi: 10.1016/j.jacc.2010.06.062
  47. Stecker EC, Vickers C, Waltz J, et al. Population-Based Analysis of Sudden Cardiac Death With and Without Left Ventricular Systolic Dysfunction: Two-Year Findings from the Oregon Sudden Unexpected Death Study. J Am Coll Cardiol. 2006;47(6):1161-6. doi: 10.1016/j.jacc.2005.11.045
  48. Selvanayagam JB, Hartshorne T, Billot L, et al. Cardiovascular magnetic resonance-GUIDEd management of mild to moderate left ventricular systolic dysfunction (CMR GUIDE): Study protocol for a randomized controlled trial. Ann Noninvasive Electrocardiol. 2017;22(4):e12420. doi: 10.1111/anec.12420
  49. Zaman S, Taylor AJ, Stiles M, et al. Programmed Ventricular Stimulation to Risk Stratify for Early Cardioverter-Defibrillator Implantation to Prevent Tachyarrhythmias following Acute Myocardial Infarction (PROTECT-ICD): Trial Protocol, Background and Significance. Heart Lung Circ. 2016;25(11):1055-62. doi: 10.1016/j.hlc.2016.04.007

Copyright (c) 2022 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies